Full Text (PDF)
Review Article

Dr. Mary Ellen Avery: A Pioneer in Neonatel Medicine and Surfactant Research

Kasumbiwal Ajay H., Lakhe Siddheshwar A., Mundhe Sudarshan, Priyanka Bishnoi

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Pediatric Education and Research 13(2 (Special Supplement -II)):p 512-514, July-Dec 2025. | DOI: https://doi.org/10.21088/per.2321.1644.13225.129

How Cite This Article:

Kasumbiwal Ajay H., Lakhe Siddheshwar A., Mundhe Sudarshan, et al. Dr. Mary Ellen Avery: A Pioneer in Neonatel Medicine and Surfactant Research. Pediatr. Edu. Res. 2025; 13(2): 512-514.

Timeline

Received : December 10, 2025         Accepted : December 21, 2025          Published : December 30, 2025

Abstract

Dr. Mary Ellen Avery was a pioneering American pediatrician whose landmark dis covery trans formed neonatal medicine. In the 1950s, she identified surfactant deficiency as the fundamental cause of respiratory dis trees s syndrome (RDS) in premature infants. This breakthrough not only clarified the pathophysiology of a major neonatal killer but also laid the foundation for the development of surfactant replacement therapy, a treatment that has saved hundreds of thousands of newborn lives worldwide. Her early influences included mentors hip from Dr. Emily Bacon, which s haped her pursuit of pediatrics and research. After excelling academically at Wheaton College and Johns Hopkins University, Dr. Avery advanced her scientific career through rigorous work at Harvard Medical School. She later became the firs t woman to chair a major department at Harvard and the firs t woman physician-in-chief at Boston Children’s Hospital. Des pit gender-based barriers, her persistence, intellectual curiosity, and commitment to integrating research with clinical care established her as a leader in neonatology. Dr. Avery’s legacy continues to guide pediatricians, highlighting the impact of scientific inquiry, mentors hip, and resilience in advancing child health. Key Messages: Surfactant deficiency identified by Dr. Avery trans formed the understanding of neonatal RDS. Her work proved how scientific research can directly improve survival in premature infant’s . Her careers how’s the importance of perseverance, mentors hip, and curios ity in medicine.


References

  • 1.   Warburton D. A personal appreciation of Mary Ellen Avery for World Prematurity Day. American Journal of Physiology-Lung Cellular and Molecular Physiology. 2022 Nov 1; 323(5): L640-2.
  • 2.   Pincock S. Mary Ellen Avery. The Lancet. 2012 Feb 18; 379(9816): 610.
  • 3.   Stark A.R. My tribute to Mary Ellen Avery. Frontiers in Pediatrics. 2014 Jun 2; 2: 50.
  • 4.   Torday J.S. Mary Ellen Avery’s research career–remembrance of things past. Frontiers in Pediatrics. 2014 Apr 28; 2: 34.
  • 5.   Hostetter M.K. Introduction of the American Pediatric Society’s 2005 John Howland Award Recipient, Mary Ellen Avery, MD. Pediatric Research. 2005 Dec; 58(6): 1311-6.
  • 6.   Avery G.B. Avery’s neonatology: pathophysiology & management of the newborn. Lippincott williams & wilkins; 2005.
  • 7.   Bearer C.F. How Mary Ellen Avery influenced my career as an investigator. Frontiers in Pediatrics. 2014 Apr 24; 2: 20.
  • 8.   Sunday M.E. Mel Avery: mentor, role model, friend, mother of us all. Frontiers in Pediatrics. 2014 Mar 31; 2: 18.
  • 9.   Floros J. In Remembrance of Dr. Mary Ellen Avery. Frontiers in Pediatrics. 2014 Mar 21; 2: 21.

Data Sharing Statement

There are no additional data available. All raw data and code are available upon request.

Funding

This research received no funding.

Author Contributions

All authors contributed significantly to the work and approve its publication.

Ethics Declaration

This article does not involve any human or animal subjects, and therefore does not require ethics approval.

Acknowledgements

We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.

Conflicts of Interest

No conflicts of interest in this work.


About this article


Cite this article

Kasumbiwal Ajay H., Lakhe Siddheshwar A., Mundhe Sudarshan, et al. Dr. Mary Ellen Avery: A Pioneer in Neonatel Medicine and Surfactant Research. Pediatr. Edu. Res. 2025; 13(2): 512-514.


Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Received Accepted Published
December 10, 2025 December 21, 2025 December 30, 2025

DOI: https://doi.org/10.21088/per.2321.1644.13225.129

Keywords

Mary Ellen AveryRespiratory Distress SyndromeSurfactant DeficiencyNeonatologyPediatric ResearchPrematuritySurfactant TherapyHarvard Medical SchoolBoston Children’s HospitalChild Health

Article Level Metrics

Last Updated

Thursday 30 July 2026, 07:14:33 (IST)


1422

Accesses

9
175
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received December 10, 2025
Accepted December 21, 2025
Published December 30, 2025

licence


Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Access this article



Share